OBJECTIVE: Attention-deficit hyperactivity disorder (ADHD) is overrepresented among
adults and adolescents in treatment for substance abuse. This study was designed to assess …

Objective: The extant literature does not provide definite answers pertaining to whether
stimulant treatment increases, decreases, or does not affect the risk for subsequent …

ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) IS ESTIMATED to affect 2%–
6% of adults. The symptoms in adults with ADHD mirror those in children with the disorder …

CONTEXT: Substance use disorders (SUD) are a major public health problem. Attention
deficit hyperactivity disorder (ADHD) is a comorbid condition associated with both onset and …

This report examines the developmental relationship between attention-deficit/hyperactivity
disorder (ADHD) and substance use disorders (SUD) and associated concurrent disorders …

Attention‐deficit hyperactivity disorder (ADHD), characterized by restless, inattentive and
hyperactive behaviours, is a relatively common childhood disorder that affects approximately …

The prevalence of attention-deficit/hyperactivity disorder (ADHD) in adults 18–44 years of
age ranges from 4.4% to 5.2%. The proportion of those adults who receive pharmacologic or …

BackgroundAttention-deficit hyperactivity disorder (ADHD) is linked to increased risk for
substance use disorders and nicotine dependence. AimsTo examine the effects of stimulant …

The prevalence rate of adult attention-deficit/hyperactivity disorder (ADHD) indicates that
4.5% of adults continue to exhibit ADHD from childhood. Most adult sufferers of ADHD have …

Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably
intertwined. Children with ADHD are more likely than peers to develop substance use …